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Results: Baseline demographic and clinical characteristics were
similar in the 800 patients without previous CMC (group-1) and the
80 patients with previous CMC (group-2) during the procedure. In
thewhole study groupmitral valve area (MVA) was 0.85 ± 0.09 cm2
prior to PTMC, and increased to 1.76 ± 0.07 cm2 after the proce-
dure (p ¼ 0.0001). The mean increase in MVA was 0.78 ± 0.31 cm2
in the group-1 and 0.79 ± 0.41 cm2 in the group-2 (NS). During the
procedure or in-hospital after PTMC, embolic events were recor-
ded in 3 patients in group-1 and 2 patients in group-2 (NS). The
frequency of minor haematoma at puncture site in 15 patients in
group-1 vs 13 patients in group-2 and the development of peri-
cardial temponade and urgent pericardiocentesis in 3 patients in
group-1 vs 3 patients in group-2, were similar in both groups.
Conclusion: PTMC in selected patients withmitral restenosis after
previous surgical commissurotomy (CMC)can be performed safely
and with similar immediate efficacy and in-hospital outcome in
patients with Mitral stenosis.
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Background: Though the mitral annulus is an important compo-
nent of the mitral valve apparatus, there is little data on how it is
influenced by MS. We hypothesized that mitral annular (MA) dy-
namics are affected with increasing disease severity. We studied
acute alterations in MA dynamics in subjects undergoing BMV
using 3D transthoracic echocardiography (TTE) and explore their
role in predicting successful outcomes.
Methods: We prospectively enrolled consecutive subjects with
rheumatic MS in sinus rhythm. 41 MS subjects (36 ± 6 years; 70%
female) comprising mild (MVA  1.5 cm2; n ¼ 10), moderate (MVA
¼ 1.1 to 1.49 cm2; n¼13) and severe (MVA  1.0cm2; n ¼ 18) MS
subgroups were analyzed. Subjects with > grade I MR, mitral
annular calcification, hypertension, multi-valve or coronary ar-
tery disease, and LV dysfunction were excluded. All subjects un-
derwent 2D TTE and 3D TTE in keepingwith current guidelines. 3D
parameters including MA dimensions, antero-posterior and inter-
commissural diameters, systolic annular displacement and
displacement velocity were measured offline. Subjects were also
stratified based on mean value of annular displacement into low
MA ( 6.3 cm; n ¼20) and high MA (>6.3 cm; n ¼ 21) subgroups.
30 subjects (37 ± 8 years; 70% Female) with MS in sinus rhythm
were selected to undergo PTMC. MS subjects underwent an
additional study 24-48 hours after PTMC. 3D TTE based mitral
annular (MA) dimensions, non planar angle, annular displace-
ment and displacement velocities were measured offline
Results: Subjects with severe MS showed reduced annular
displacement (4.7 ± 2 vs. 9.8 ± 1.5cm; p < 0.01) and displacement
velocities (26.2 ± 8 vs. 41.6 ± 7cm/s; p <0.01) as compared to mild
MS, in addition to demonstrating higher mean gradient, LA vol-
ume and RVSP (p<0.001 for all variables). MA dimensions and
orthogonal diameters were not significantly different between
subgroups, though with increasing stenosis severity, a tendency
towards increased annular flattening was observed. MA
displacement was strongly correlated with valve area (r ¼ 0.74;
p<0.001), mean gradient (r ¼ -0.60; p<0.001) and RVSP (r ¼ -0.62;
p<0.001). Subjects with low MA displacement demonstrated
significantly smaller Mitral Valve Area (BMV) (0.8 ± 0.2vs. 1.3 ±
0.4cm2;p<0.001), highermean gradient (18 ± 7 vs. 10 ± 7mmHg; p¼
0.03) and RVSP ( 64 ± 29 vs. 35 ± 10mmHg ; p ¼ 0.001) as compared
to the high MA displacement subgroup.
In patients who underwent BMV, MVA increased (0.8 ± 0.1 to
1.63 ± 0.2 cm2) and transmitral mean gradient (19 ± 7 to 4 ±2 mm
Hg) and LA indexed volumes were reduced (71 ± 23 to 53 ± 18 mm
Hg)(p < 0.001 for all variables). Additionally, both annular
displacement (5.5 ± 2.0 to 7.4 ± 1.8cm; p < 0.01) and non planar
angles (153 ± 10 to 145 ± 8 degrees; p < 0.01) tended to normalize.
Subjects with unsuccessful outcomes (MVA < 1.5 cm2 or > grade II
MR; n ¼ 7) demonstrated no significant differences in Wilkins
score as compared to those with successful outcomes (10± 1.4 vs.
9.6 ± 0.7; n ¼ 23), but showed smaller anteroposterior diameters (
3.0 ± 0.1 vs. 3.3 ± 0.2; p < 0.05) and Ao-AP angles (139 ± 15 vs. 159 ±
10 degrees).
Conclusion: Mitral annular displacement and velocity are
decreased in severe MS. Progressive reduction in mitral annular
dynamics are associated with increasing disease severity. 3D TTE
derived MA dynamics demonstrate potential as novel additional
parameters to quantify MS severity.
MA displacement and velocity increases post BMV in patients
with MS, suggesting an improvement in MA dynamics and
normalization of 3D annular geometry. MA dynamics varied
significantly in patients with successful vs. unsuccessful BMV,
despite similar Wilkins score. MA dynamics may be a useful
marker to assess severity of MS and likelihood of success in pa-
tients undergoing BMV.
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Background: Rheumatic heart disease (RHD) is the most common
cause of valvular heart disease in India and other developing
countries accounting for 25-45% of acquired heart disease. RHD
especially regurgitant lesions of mitral and aortic valve and Aortic
stenosis are associated with left ventricular systolic dysfunction
later in their natural history. It is not clear based on present data,
whether this LV dysfunction is fully reversible if the mechanical
component is corrected by surgery. Cardiac magnetic resonance
imaging (MRI) to detect significant myocardial fibrosis may help
detecting patients with irreversible myocardial dysfunction with
poor recovery of LV function after surgery.
Methods:We retrospectively reviewed the records of RHD patients
with LV (Left ventricular) dysfunction (Left ventricular ejection
fraction, LVEF < 50%) by echocardiogram who underwent Cardiac
MRI. Patients with history or any evidence of previous acute cor-
onary syndrome or coronary artery disease, any other cardiomy-
opathies were excluded. We analysed what percentage of these
patients had significant late gadolinium enhancement (LGE) sug-
gestive of fibrosis on cardiac MRI, whether there was any corre-
lation of LGE with the degree of LV dysfunction and whether any
specific pattern of LGE was present in RHD patients.
Results: Cardiac MRI data of 17 patients (14 (82%)male) withmean
age 47.8 years (range 29-61) were analysed. 15 of the 17 patients
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underwent a coronary angiogram which was normal. 14 patients
(82%) hadmitral valve disease (78% of whom had dominant mitral
stenosis with mild or no regurgitation, 22% had atleast moderate
mitral regurgitation), 3 patients has significant combined valve
disease. Six patients (35%) hadmild LV dysfunction (LVEF 41-50%),
9 patients (52%) hadmoderate LV dysfunction (LVEF 31-40%) and 2
patients (13%) had severe LV dysfunction (LVEF 30%). Thirteen
patients (76%) were in atrial fibrillation and 4 patients (24%) were
in sinus rhythm. There was a good correlation between echocar-
diographic and Cardiac MRI derived LVEF (Correlation coefficient
0.82). Only 2 of the 17 patients showedmyocardial LGE. There was
no correlation between the LVEF and presence of LGE. One pa-
tients had subendocardial and midmyocardial enhancement of
Inferoseptum and one had enhancement of papillary muscles.
LGE of valves was observed in 16 out of 17 patients (mitral valve in
94%, aortic valve in 35% and tricuspid valve in 29% patients).
Enhancement of the Left atrial wall or interatrial septumwas seen
in 7 patients (41%), six of whom had atrial fibrillation.
Conclusion: This study shows that majority of RHD patients with
LV dysfunction, even those with severe LV dysfunction have no
myocardial fibrosis as indicated by LGE on cardiac MRI suggesting
good LV function recovery after valve surgery. Prospective studies
with larger sample size with postoperative follow-up are required
to confirm these findings.
Prospective study of infective endocarditis in a
tertiary care centre in Kerala: Prognostic role of
baseline ESR Vs. CRP
Sandeep Mohanan, G. Rajesh, V. Haridasan, C.G. Sajeev,
M.N. Krishnan
Calicut Government Medical College, Calicut, India
Background: Prognostic categorization of infective endocarditis
patients has been difficult in lieu of the poor correlation between
baseline clinical parameters and outcomes. Previous studies have
identified the importance of prosthetic valve involvement,
staphylococcal infection, large vegetations>10mm, neurological
involvement and renal dysfunction. However baseline inflam-
matory markers have not found a definite prognostic role in pa-
tient stratification. We conduct a prospective analysis of all
infective endocarditis patients admitted to our centre and in this
subanalysis we specifically look into the value of erythrocyte
sedimentation rate (ESR) or C-reactive protein(CRP) as a prog-
nostic marker.
Methods: The study population included all patients who were
admitted according to the Duke’s criteria of infective endocarditis.
Erythrocyte sedimentation rate was estimated by theWestergrens
method from our hospital laboratory. CRP was estimated by
turbidimetric method. To strengthen the value of our data for this
analysis we excluded all patients who had received parenteral
antibiotic therapy or recent oral antibiotic therapy. Microbiolog-
ical techniques were optimized and institutional protocol was
followed. Six month follow up data following discharge was
collected.
Results: A total of 76 patients were admitted and treated for
infective endocarditis. Out of this 52 had definite endocarditis. 45
patients (59%) were blood culture positive and of them 28 (62%)
had Staphylococcus infection. 16 patients (57% of Staphylococcus)
had methicillin resistance. 63% had atleast NYHA II heart failure,
26% had embolic complication, 10% had neurological
complications and 23% had to undergo early surgery. 17 pa-
tients(23%) died in-hospital and this rose to 22 patients at 6
months (29%). The mean ESR was 101mm/hour and CRP was
42mg/dl. ESR and CRP had high sensitivity for the diagnosis of
infective endocarditis by the Duke criteria (99% and 90% respec-
tively). ESR and CRP values had poor correlation with microbio-
logical yield, vegetation size or need for surgery. However a CRP
level >46mg/dl was shown to predict mortality and embolic phe-
nomenon in infective endocarditis patients with a sensitivity of
72% and specificity of 81%.
Conclusion: Major complications and mortality continue to
remain high even in the current era of management in infective
endocarditis patients admitted to a tertiary care centre. In addi-
tion to its diagnostic utility, elevated CRP levels have prognostic
value in predicting mortality and embolic phenomenon in these
patients.
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Background: Since the introduction of the Inoue technique for
percutaneous transvenous mitral commissurotomy (PTMC),
various criteria have been proposed for ideal balloon sizing. In
routine practice, balloon size is chosen based on the patient’s
height according to a simple formula. We tried to define a
simple and practical echocardiographic measure for adjusting
balloon size to achieve better success rates and fewer
complications.
Methods: Patients with moderate to severe mitral stenosis who
were candidates for PTMC were selected. Maximal mitral inter-
commissural diameter at a fully opened state during diastole was
measured by transthoracic echocardiography (both 2D & 3D) and
compared with the values from the height-based formula. Data
were compared by paired sample t-test.
Results: Thirty-six patients [25 (69.4%) women; mean age 31.2 ±
11.6 years] participated. Themean estimated balloon size was 25.5
± 1.0 mm according to height and 24.3 ± 1.5 mm based on inter-
commissural diameter. According to the patients’ need, the
average final size of balloons used during PTMCwas 24.8 ± 1.2mm
(range 22e28 mm). The height-based formula estimated the sizes
as being greater (mean difference¼0.64 ± 0.8 mm) and echocar-
diography estimated the sizes as being smaller (mean differ-
ence¼0.45 ± 0.8 mm) than the final balloon sizes used during
PTMC. Using a Bland-Altman plot, an excellent agreement was
observed between the two methods. Certain 3D echocardio-
graphic parameters like the MV volume (p¼0.0002), the submitral
volume (p¼0.0005), total MV apparatus volume (p¼0.01), annulus
diameter (p¼0.004) and inter-commissural diameter (0.01) were
significantly related to a successful PTMC.
Conclusions: Selection of balloon size according to echocardio-
graphic commissural diameter is a good alternative method.
Assuming the possible discrepancy between height-based and
commissural-based estimated balloon sizes in some cases,
adjustment of balloon sizes according to the maximal commis-
sural diameter may result in acceptable results and fewer com-
plications.
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